This report contains market size and forecasts of Alzheimer's Disease Therapeutics and Diagnostics in Global, including the following market information:
Global Alzheimer's Disease Therapeutics and Diagnostics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Alzheimer's Disease Therapeutics and Diagnostics market was valued at 6787.4 million in 2020 and is projected to reach US$ 7829.6 million by 2027, at a CAGR of 3.6% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alzheimer's Disease Therapeutics and Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alzheimer's Disease Therapeutics and Diagnostics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Alzheimer's Disease Therapeutics and Diagnostics Market Segment Percentages, By Type, 2020 (%)
Diagnostics
Treatment
China Alzheimer's Disease Therapeutics and Diagnostics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Alzheimer's Disease Therapeutics and Diagnostics Market Segment Percentages, By Application, 2020 (%)
Marketed Drugs
Pipeline Drugs
Global Alzheimer's Disease Therapeutics and Diagnostics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Alzheimer's Disease Therapeutics and Diagnostics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Alzheimer's Disease Therapeutics and Diagnostics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Alzheimer's Disease Therapeutics and Diagnostics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Pfizer
Eisai
Novartis
Forest Laboratories
TauRx Therapeutics
AC Immune
Johnson & Johnson.
H. Lundbeck
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Alzheimer's Disease Therapeutics and Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alzheimer's Disease Therapeutics and Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alzheimer's Disease Therapeutics and Diagnostics Overall Market Size
2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size: 2021 VS 2027
2.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Alzheimer's Disease Therapeutics and Diagnostics Players in Global Market
3.2 Top Global Alzheimer's Disease Therapeutics and Diagnostics Companies Ranked by Revenue
3.3 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Alzheimer's Disease Therapeutics and Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Alzheimer's Disease Therapeutics and Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alzheimer's Disease Therapeutics and Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Alzheimer's Disease Therapeutics and Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Alzheimer's Disease Therapeutics and Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Markets, 2021 & 2027
4.1.2 Diagnostics
4.1.3 Treatment
4.2 By Type - Global Alzheimer's Disease Therapeutics and Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Alzheimer's Disease Therapeutics and Diagnostics Revenue, 2016-2021
4.2.2 By Type - Global Alzheimer's Disease Therapeutics and Diagnostics Revenue, 2022-2027
4.2.3 By Type - Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2021 & 2027
5.1.2 Marketed Drugs
5.1.3 Pipeline Drugs
5.2 By Application - Global Alzheimer's Disease Therapeutics and Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Alzheimer's Disease Therapeutics and Diagnostics Revenue, 2016-2021
5.2.2 By Application - Global Alzheimer's Disease Therapeutics and Diagnostics Revenue, 2022-2027
5.2.3 By Application - Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global Alzheimer's Disease Therapeutics and Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Alzheimer's Disease Therapeutics and Diagnostics Revenue, 2016-2021
6.2.2 By Region - Global Alzheimer's Disease Therapeutics and Diagnostics Revenue, 2022-2027
6.2.3 By Region - Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Alzheimer's Disease Therapeutics and Diagnostics Revenue, 2016-2027
6.3.2 US Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.3.3 Canada Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.3.4 Mexico Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue, 2016-2027
6.4.2 Germany Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.4.3 France Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.4.4 U.K. Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.4.5 Italy Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.4.6 Russia Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.4.7 Nordic Countries Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.4.8 Benelux Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Alzheimer's Disease Therapeutics and Diagnostics Revenue, 2016-2027
6.5.2 China Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.5.3 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.5.4 South Korea Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.5.5 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.5.6 India Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Alzheimer's Disease Therapeutics and Diagnostics Revenue, 2016-2027
6.6.2 Brazil Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.6.3 Argentina Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Revenue, 2016-2027
6.7.2 Turkey Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.7.3 Israel Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.7.4 Saudi Arabia Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
6.7.5 UAE Alzheimer's Disease Therapeutics and Diagnostics Market Size, 2016-2027
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Major Product Offerings
7.1.4 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Eisai
7.2.1 Eisai Corporate Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Alzheimer's Disease Therapeutics and Diagnostics Major Product Offerings
7.2.4 Eisai Alzheimer's Disease Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.2.5 Eisai Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Alzheimer's Disease Therapeutics and Diagnostics Major Product Offerings
7.3.4 Novartis Alzheimer's Disease Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.3.5 Novartis Key News
7.4 Forest Laboratories
7.4.1 Forest Laboratories Corporate Summary
7.4.2 Forest Laboratories Business Overview
7.4.3 Forest Laboratories Alzheimer's Disease Therapeutics and Diagnostics Major Product Offerings
7.4.4 Forest Laboratories Alzheimer's Disease Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.4.5 Forest Laboratories Key News
7.5 TauRx Therapeutics
7.5.1 TauRx Therapeutics Corporate Summary
7.5.2 TauRx Therapeutics Business Overview
7.5.3 TauRx Therapeutics Alzheimer's Disease Therapeutics and Diagnostics Major Product Offerings
7.5.4 TauRx Therapeutics Alzheimer's Disease Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.5.5 TauRx Therapeutics Key News
7.6 AC Immune
7.6.1 AC Immune Corporate Summary
7.6.2 AC Immune Business Overview
7.6.3 AC Immune Alzheimer's Disease Therapeutics and Diagnostics Major Product Offerings
7.6.4 AC Immune Alzheimer's Disease Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.6.5 AC Immune Key News
7.7 Johnson & Johnson.
7.7.1 Johnson & Johnson. Corporate Summary
7.7.2 Johnson & Johnson. Business Overview
7.7.3 Johnson & Johnson. Alzheimer's Disease Therapeutics and Diagnostics Major Product Offerings
7.4.4 Johnson & Johnson. Alzheimer's Disease Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.7.5 Johnson & Johnson. Key News
7.8 H. Lundbeck
7.8.1 H. Lundbeck Corporate Summary
7.8.2 H. Lundbeck Business Overview
7.8.3 H. Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Major Product Offerings
7.8.4 H. Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.8.5 H. Lundbeck Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Alzheimer's Disease Therapeutics and Diagnostics Market Opportunities & Trends in Global Market
Table 2. Alzheimer's Disease Therapeutics and Diagnostics Market Drivers in Global Market
Table 3. Alzheimer's Disease Therapeutics and Diagnostics Market Restraints in Global Market
Table 4. Key Players of Alzheimer's Disease Therapeutics and Diagnostics in Global Market
Table 5. Top Alzheimer's Disease Therapeutics and Diagnostics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Alzheimer's Disease Therapeutics and Diagnostics Product Type
Table 9. List of Global Tier 1 Alzheimer's Disease Therapeutics and Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alzheimer's Disease Therapeutics and Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type